Veeva Launches Innovative eSource Application for Clinical Research
In a pivotal stride towards enhancing clinical research efficiency, Veeva Systems (NYSE: VEEV) has officially unveiled its latest application, Veeva eSource. This innovative tool is embedded within the Veeva SiteVault, designed specifically to ease the burdens associated with manual clinical trial processes and significantly improve data quality.
The Future of Clinical Trials
Clinical trials have long been plagued by slow and cumbersome paperwork, a challenge that Veeva eSource seeks to tackle head-on. By digitizing data collection, the application enables research sites to gather information without the redundant paper trail typically associated with such processes.
Alisha Garibaldi, CEO of Skylight Health Research, expressed her enthusiasm: “The traditional eSource systems have proven to be sluggish when it comes to programming, completing, and transferring necessary data. Veeva eSource promises a seamless flow of information that minimizes errors, reduces quality control handling, and allows us to focus more on patient care.”
Key Features of Veeva eSource
1.
Integration with Electronic Health Records (EHR)
- Veeva eSource allows for effortless integration with existing EHR systems, enabling the automatic transfer of relevant patient data into the eSource application. This feature eliminates unnecessary data duplication, easing the workload of both research sites and patients.
2.
Direct Data Capture Application
- The platform includes an intuitive application specifically designed for capturing trial data digitally. Research centers can now collect data without relying on outdated paper methods, creating a unified experience that supports both participants and site staff throughout the trial process.
3.
EDC Integration
- One of the standout features of Veeva eSource is its capability to connect seamlessly with Electronic Data Capture (EDC) systems. This integration automates patient data flow from eSource to Veeva EDC, minimizing latency and reducing the likelihood of errors. Furthermore, the bi-directional connection aids in easily adapting study protocols from EDC to eSource, allowing for straightforward form generation tailored to study designs.
4.
Elimination of Source Data Verification (SDV)
- By utilizing source data instead of transcribed entries, the need for traditional SDV practices is eradicated. This advancement offers sponsors more time for productive engagement with research sites, enhancing operational efficiency.
“Veeva eSource marks a significant leap in our efforts to create a more connected and streamlined clinical trial process,” explained Jim Reilly, president of Veeva Development Cloud. This application not only standardizes but also simplifies trials, improving the overall experiences of sponsors, research centers, and patients alike.
Nick Frenzer, Veeva's general manager for site solutions, added, “With the introduction of eSource, we enhance the transparency of data across the board within clinical trials, facilitating higher efficacy and simplicity.”
Looking Ahead
Veeva eSource is a crucial element of the Veeva SiteVault platform and will be made available for initial users in the second half of 2026. This rollout is highly anticipated in a field that continuously seeks to balance technological innovation with the imperative of patient-centric research.
About Veeva Systems
Veeva Systems specializes in providing cloud-based solutions for life sciences with a clear focus on software, data, and business consulting. The company is committed to innovation and client success, serving a diverse clientele including both established pharmaceutical companies and emerging biotechs. With an ethos of balancing stakeholder interests, Veeva aims to be a leader in enhancing the productivity of clinical trials through digital advancements.
For more information, visit
veeva.com.